FDA OKs CSL’s new HAE drug, already embroiled in a blockbuster fight with Shire
CSL Behring’s Bern, Switzerland manufacturing campus
CSL Behring has picked up an FDA OK to start marketing its new drug for rare cases …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
